cyclin dependent kinase-4 peptide fragments (TheRyte)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namecyclin dependent kinase-4 peptide fragments (TheRyte)
Drug Alias NameAc-Pro-Arg-Gly-Pro-Arg-Pro-NH2CDK-4 peptide fragment (TheRyte)THR-53THR-93
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCyclin-dependent kinase 4 modulators
TargetsCyclin-dependent kinase 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTheryte Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheryte Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A